Boston

3 Ways to Get the Most Out of Pharma MES USA 2026 (Boston)

Pharma MES USA 2026 conference is fast approaching, bringing together pharmaceutical and biotech manufacturing leaders to discuss the future of digital production. The event takes place March 23–24, 2026 at Encore Boston Harbor, bringing together senior leaders from manufacturing, IT/OT, digital transformation, and quality.

As pharmaceutical manufacturers continue modernizing operations, Manufacturing Execution Systems (MES) are playing an increasingly important role in how organizations digitize production, manage compliance, and capture manufacturing data. Conferences like Pharma MES USA provide an opportunity to exchange real-world lessons about MES implementation, modernization strategies, and the next phase of digital manufacturing.

Before diving into the agenda, it’s helpful to understand the major themes shaping this year’s conversations.

Key Themes Shaping Pharma MES USA 2026

Several topics are expected to influence discussions across the program as organizations continue evolving their digital manufacturing strategies.

  • MES as the Digital Backbone of Pharmaceutical Manufacturing. Manufacturers are expanding the role of pharma MES software beyond batch execution, using MES as the operational hub connecting enterprise systems, automation, and quality processes.
  • Electronic Batch Records and Review by Exception. The shift from paper to electronic batch records (EBR) remains a key driver of pharmaceutical MES adoption, with Review by Exception helping quality teams accelerate batch review and improve compliance.
  • MES Lifecycle Management and Modernization. Many pharmaceutical companies are evaluating aging MES platforms and determining how to modernize systems while maintaining validated manufacturing environments.
  • Manufacturing Data and AI-Driven Insight. As more production data becomes available digitally, manufacturers are exploring how MES data can support analytics, dashboards, and AI-driven insights.
  • Connected Manufacturing and IT/OT Convergence. Pharmaceutical MES platforms are increasingly central to connected manufacturing architectures linking automation, enterprise systems, and quality processes.

These themes reflect the broader shift toward more connected, data-driven pharmaceutical manufacturing environments.

1. Prioritize Sessions Addressing Real MES Program Challenges

One of the most valuable aspects of Pharma MES USA is the opportunity to hear how other organizations are navigating complex MES programs.

Several sessions will focus on practical challenges that frequently arise during MES initiatives.

 

Business requirements: How to understand the business needs and define the right requirements for MES to improve the MES vendor selection process and implementation strategy?
March 23, 2026 | 16:45 – 17:45

Defining clear business requirements remains one of the most critical steps in successful MES programs. This session will explore how organizations can develop effective User Requirements Specifications (URS) and structure vendor evaluation processes that support long-term operational goals.

These discussions are particularly valuable for teams currently evaluating pharmaceutical MES software or planning future digital manufacturing initiatives.

 

The Evolution of MES — From Execution Layer to Manufacturing Intelligence Platform Driven by AI
March 23, 2026 | 09:55 – 10:25

As digital manufacturing initiatives mature, attention is increasingly shifting toward how structured production data captured by MES platforms can support advanced analytics, operational dashboards, and AI-driven decision-making.

 

Vertex: Upgrading MES with Confidence — Accelerating Transitions, Ensuring Compliance, and Maximizing Value
March 23, 2026 | 11:00 – 11:25

Vertex will share lessons learned from its five-year MES journey, including implementation experience in cell and gene therapy clinical environments and its transition from Computer System Validation (CSV) to Computer System Assurance (CSA).

Real-world case studies like this provide valuable insight into implementation planning, validation strategy, and long-term MES lifecycle management.

 

2. Take Advantage of Structured Networking Opportunities

Beyond the formal sessions, Pharma MES USA is designed to encourage meaningful peer exchange throughout the program.

These conversations often provide valuable insight into how organizations are approaching MES modernization and digital manufacturing strategy.

 

Icebreaker Networking Session
March 23, 2026 | 07:30 – 08:20

Held before the main agenda begins, this informal gathering provides an opportunity to start conversations early and understand what challenges are top of mind across the industry.

 

World Café Roundtables
March 24, 2026 | 11:00 – 15:00

These rotating discussions focus on MES strategy, system integration, and digital manufacturing priorities, allowing attendees to exchange perspectives with organizations at different stages of MES maturity.

 

One-2-One Meetings
Throughout the Conference

Pre-scheduled meetings create space for focused conversations around MES modernization initiatives, vendor evaluations, and implementation planning.

 

3. Learn from Real MES Implementation Experience

One of the most valuable aspects of the conference is hearing directly from organizations that have already gone through MES implementation and modernization programs.

We’re particularly looking forward to hearing from Vertex, who will share lessons learned from their five-year MES journey, including implementation experience in cell and gene therapy clinical environments and their transition from Computer System Validation (CSV) to Computer System Assurance (CSA).

Real-world case studies like this provide valuable perspective on:

  • Implementation planning and change management
  • Validation and regulatory considerations
  • Long-term MES lifecycle management
  • Lessons learned from large-scale deployments

These insights often provide practical guidance that organizations can apply directly to their own MES initiatives.

Hear Insights from the POMS Team

Members of the POMS leadership team will participate in a panel discussion during the event, Agile MES for Clinical Manufacturing — Designing Execution Systems for a New Era of Therapies, sharing practical insights drawn from real MES implementations in regulated pharmaceutical manufacturing environments.

March 23, 2026 | 7:35pm-8:20pm

Panel participants include:

  • Roland Esquivel — Moderator: Vice President, Global Sales & Marketing, POMS Corporation
  • Cherie Young — Quality Manager, POMS Corporation
  • Kate Porter — Director of Product, POMS Corporation
  • Moaz Afzal — POMS Consultant
  • Jay Segal — Business Systems Sr. Manager, Vertex Pharmaceuticals

Let’s Connect in Boston

Manufacturing Execution Systems continue to play a critical role in enabling compliant, data-driven pharmaceutical manufacturing. Conferences like Pharma MES USA provide a valuable opportunity to exchange insights and explore how MES strategies are evolving across the industry.

If you’ll be attending, we encourage you to:

📍 Visit the POMS team at Booth #41

🤝 Share your MES priorities and challenges

📅 Continue the conversation around MES modernization and digital manufacturing strategy

We look forward to connecting in Boston at Pharma MES USA 2026.